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Introduction
Polymeric amphiphiles have proven to be an excellent alternative to low molecular weight surfactants for drug solubilisation [1] [2] [3] . In aqueous environments, they spontaneously aggregate into micelle-like aggregates via hydrophobic-hydrophobic interactions [4] . Polymeric nano-aggregates can be formed from a diverse range of architectures including block copolymers [5] , graft polymers [6] , star shaped polymers [7] and dendrimers [8] .
Graft polymers consist of a water-soluble homopolymer backbone with hydrophobic groups 'grafted' onto this to form a comb shaped structure [9] . Commonly, poly(ethylenimine) [10] , poly(allylamine) [11] and chitosan [12] backbones have been used in the formation of these macromolecules. Previous work has reported the promising potential of poly(allylamine) (PAA) grafted with cholesteryl and dansyl moieties to act as universal hydrophobic drug solubilizers [13] . Model drugs included 2,6-diisopropylphenol (propofol), 11β-11,17,21-trihydroxypregna-1,4-diene-3,20-dione (prednisolone) and (2S,6'R)-7-chloro-2',4,6-trimethoxy-6'-methyl-3H,4'H-spiro[1-benzofuran-2,1'-cyclohex [2] ene]-3,4'-dione (griseofulvin) [13] .
In recent years, magnetic iron oxide nanoparticles have been widely studied for biomedical and electronic applications. These applications include: detection at the cellular level, imaging using nuclear magnetic resonance imaging (MRI), targeted drug delivery and gene therapy, waste water treatment and electronics [14] [15] [16] [17] [18] . Iron oxide nanoparticles possess a large surface area to volume ratio due to their nano-size, a low surface charge at physiological pH and they also aggregate in solution due to their inherent magnetic properties. The subsequent stability problems in solution can be overcome by surface engineering of the particles with coatings such as silica and polymers [14, 19] . However, in the last few years, increasing concern has arisen over the safety of polymer coated iron oxide nanoparticles [20] [21] [22] . This culminated in the withdrawal of Feridex ® from use in humans in the United Kingdom in 2012. It is proposed that the degradation of the flexible polymer coating leads to iron oxide core exposure, resulting in free radical production and, ultimately, cellular stress or mortality [21, 23, 24] . The need for a robust coating has therefore led to the recent development of gold-iron oxide hybrid nanoparticles (HNPs) [25] . Gold is renowned for its chemical stability and biocompatibility in the nano-shell structure [26] . Gold nanostructures can be further functionalised using molecules that possess a thiol group which are strongly adsorbed onto the gold surface [27] . Previous studies investigating HNP fabrication have shown that the insertion of an organic intermediate between the iron oxide core and gold coating helps to preserve the unique characteristics of both the iron oxide and gold components [25, 28] . A recent study has also investigated the effect of the hybrid composition on HNP physicochemical properties, i.e., changing the core size, coating thickness etc. in order to harvest optimal particles [28] . Additionally, in vitro biocompatibility testing has reported no considerable HNP degradation or toxic effect [29] . Thus, indicating the suitability of these HNPs for biomedical application.
The incorporation of polymeric amphiphiles and HNPs into a single platform may therefore create a bifunctional system capable of dual imaging and drug delivery of active pharmaceutical ingredients. In this study we aim to graft water-soluble PAA with 5-(4-chlorophenyl)-1,3,4-oxadiazole-2-thiol (oxadiazole, Ox) in a 5%
monomer:pendant group ratio (PAA-Ox 5 ). The oxadiazole moiety is hydrophobic due to its aromatic structure and also possesses a thiol (SH) functionality. This pendant group will act as a site of permanent conjugation for the HNPs; achieved through the strong dative covalent attachment between the thiol and colloidal gold surface.
The physicochemical properties of the novel PAA-Ox 5 will be investigated both before and after HNP conjugation. The potential of these nano-aggregates as drug cargo carriers in the aqueous environment will also be investigated. The model hydrophobic drugs propofol and griseofulvin will be used to determine optimal drug solubilisation parameters. Propofol is the most commonly used intravenous anaesthetic agent in the world owing to its rapid onset, short half-life and minimal side-effect profile [30] . The highly lipophilic nature of the compound (logP 4.16) hinders its formulation as an aqueous-based injection. Early propofol formulations utilised Cremophor EL (a non-ionic surfactant) in water but were associated with characteristic adverse effects including severe anaphylactic hypersensitivity reactions [31] . Subsequently, propofol was reformulated into a microemulsion formulation (e.g. Diprivan®) which is still the current preparation used clinically [32] .
However, some limitations remain, including pain upon injection and support for bacterial growth [33] .
Griseofulvin is a lipophilic drug with an aqueous solubility of 30 µgmL -1 at 25 ºC [34] . The antifungal properties of griseofulvin are exploited in both animals and humans for the treatment of dermatophyte infections [35, 36] . Its hydrophobic nature results in a low aqueous solubility in the gastrointestinal (GI) tract resulting in poor oral bioavailability [37, 38] . Griseofulvin is currently administered orally in microcrystalline preparations with prescribed doses of 500-1000 mgday -1 [39] . However, a great deal of inter-and intra-subject variation is experienced, perhaps due to erratic and incomplete absorption of the drug from the GI tract [40] . The novel anticancer drug bisnaphthalimidopropyldiaminooctane (BNIPDaoct) has been reported to possess great potential as a cytotoxic agent in pancreatic cancer treatment [41, 42] . BNIPDaoct has shown negligible aqueous solubility and as a result toxic solvents such as dimethyl sulfoxide (DMSO) have been required in order to dissolve the drug [41, 43] . Here, we will investigate the potential of the two PAA derivatives in BNIPDaoct solubilisation using the optimal formulation strategies determined. Additionally, the potential of these novel nano-aggregates to act as hydrophilic drug carriers will be investigated using 6-thioguanine (6-TG). 6-TG is an antitumour agent used clinically in the treatment of leukaemia [44] . However, its association with a large number of serious side effects such as ulcerative colitis and bone marrow toxicity, has seen its use decline in recent years [45] . 6-TG will be conjugated onto the PAA-Ox 5 -HNP surface via dative covalent bonding in a similar process to the polymer HNP conjugation. The drug conjugation capacity will be determined using PAA-Ox 5 as a control. In vitro studies in human pancreatic adenocarcinoma (BxPC-3) cells will determine the effect of drug incorporation into the PAA amphiphiles on both drug uptake and cytotoxicity.
Materials and Methods

Materials
Poly(allylamine) (PAA), 5-(4-chlorophenyl)-1,3,4-oxadiazole-2-thiol and auric chloride dihydrate were purchased from AlfaAesar (UK). Dialysis tubing membranes were purchased from Medicell International Ltd.
(UK). Syringe filters (0.22 µm), acetonitrile, methanol and dimethyl sulfoxide (DMSO) were purchased from Fisher Scientific (UK). Foetal bovine serum, Roswell Park Memorial Institute Medium (RPMI) 1640, trypsin and penicillin streptomycin were purchased from Life Technologies (UK). Human pancreatic adenocarcinoma (BxPC-3) cells were purchased from ATCC (USA). All other chemicals were purchased from Sigma-Aldrich (UK).
Methods
PAA-Ox 5 synthesis
PAA was reacted in 1:0.05 molar feed with 5-(4-chlorophenyl)-1,3,4-oxadiazole-2-thiol (Oxadiazole, Ox) (monomer: pendant). Briefly, the PAA was dissolved in 1:1 (v/v) methanol: chloroform with stirring followed by the addition of triethylamine. The reaction was stirred at room temperature for 0.5 h. The 5-(4-chlorophenyl)-1,3,4-oxadiazole-2-thiol was dissolved in 1:1 (v/v) methanol:chloroform and added drop wise to the polymer solution over 0.5 h. The reaction was stirred at 37°C for 18 h. After evaporating the solvent on a reduced pressure using a rotary evaporator the polymer residue was washed three times with diethyl ether and dried thoroughly. The residue was dissolved in deionised water and exhaustively dialysed using visking membrane 12-14 kDa against deionised water for 24 h. The resultant solution was freeze-dried. Polymer structure was characterised using proton nuclear magnetic spectroscopy ( electrostatically via probe sonication with magnetic particles in deionised water. Gold seeds (2 nm) were attached through electrostatic interaction to the polymer followed by iterative reduction of auric chloride dehydrate (HAuCl 4 ) onto the particle surface forming a complete shell. The final particles were washed extensively with deionised water to ensure excess gold was removed from the solution before resuspending in deionised water. Metal content was determined using inductively coupled plasma -optical emission spectroscopy (ICP-OES). An acid digestion was carried out in concentrated nitric acid (HNO 3 , 1:5 sample: acid) and the samples were diluted with deionised water prior to analysis. A calibration was run using iron and gold standard solutions 0.5 -5 mgmL -1 (R 2 =0.9999). The concentration of HNPs used for all experiments indicates the concentration of Fe. Maximum UV absorbance (λ max ) of HNPs was measured using a UV-2600 UV-VIS(NIR) with an ISR-2600 Plus Integrated sphere (Shimadzu, Germany) of samples in aqueous solution.
Solutions were analysed in quartz cuvettes, absorbance scans were carried out between 400 -800 nm.
Hydrodynamic diameter and polydispersity index were estimated using photon correlation spectroscopy (PCS) (Zetasizer Nano-ZS, Malvern Instruments, UK). All measurements were carried out at 25 °C (n=3). Zeta potential measurements were carried out to determine surface charge using the same instrument. Transmission electron microscopy (TEM) was used to visualise the morphology and diameter of particles on formvar-coated copper grids using a JEOL JEM-1230 microscope with ANAlysis software (JEOL, Japan). Magnetic characterisation was carried out in a Quantum Design MPMS-XL SQUID magnetometer as previously described [28] . Briefly, zero-field-cooled warming (ZFCW) and field-cooled-warming (FCW) and cooling (FCC) curves were measured between 10 and 280 K, in a field H = 8 kA/m. Magnetisation vs. applied field hysteresis loops were collected at 10 and 250 K in applied fields up to 4 MA/m.
PAA-Ox 5 -HNP conjugation
A 5 mgmL -1 PAA-Ox 5 (10 mL) solution was prepared in deionised water with probe sonication for 10 min.
HNPs (500 µL) were added into solution and the mixture was sonicated for a further 10 min.
Characterisation of PAA-Ox 5 and PAA-Ox 5 -HNP nano-aggregates
Nano-aggregates were formed in aqueous solution via probe sonication. Solutions were filtered using 0.22 µm syringe filters prior to further analysis. The critical aggregation concentration (CAC) was determined using a hydrophobic methyl orange UV probe in an adaptation of Uchegbu's method [46] . Briefly, a stock solution of methyl orange (25 μM) was prepared with sodium tetraborate buffer (0.02 M, pH 9.4) in deionised water.
Polymer solutions (0.00145 -3 mgmL -1 ) were made up using the methyl orange solution as the diluent. Each sample was probe sonicated for 5 min and allowed to cool to room temperature. The polymer solutions were measured in a UV-2600 UV-VIS(NIR) spectrometer (Shimadzu, Germany) and their maximum absorbance recorded (350-600 nm). The methyl orange stock solution was used as the control. The presence of hypsochromic shift was determined by comparing the polymer solution wavelength maxima with the λ max of methyl orange stock solution (463 nm). Photon correlation spectroscopy, zeta potential measurement, TEM imaging and magnetic characterisation was carried out as previously described.
Drug loading of nano-aggregates
Probe sonication was used to incorporate drug molecules into the self-assemblies as previously reported [11, 14] .
Aqueous polymer solutions (1, 3 and 6 mgmL -1
) were probe sonicated for 10 min. Hydrophobic drugs (propofol and griseofulvin) were added to solution using initial drug: polymer feed ratios of 1:1, 5:1 and 10:1. The solutions were sonicated for a further 10 min before cooling to room temperature. The solutions were filtered using 0.22 μm syringe filters to remove any excess unsolubilised drug molecules. Anticancer therapeutic agents 6-TG and BNIPDaoct were incorporated into the nano-aggregate structure using the optimal polymer concentration / drug feed ratio determined using the model drug studies.
Propofol, griseofulvin and 6-TG concentration were determined via absorbance measurement at 272 nm, 292 nm and 330 nm in the UV-Vis spectrophotometer, respectively. Propofol and griseofulvin measurements were achieved upon sample dilution in acetonitrile and methanol, respectively. 6-TG measurements were carried out in aqueous samples. BNIPDaoct concentration was measured using a JASCO PH-980 coupled with a JASCO the % drug loading capacity (LC) and % drug encapsulation efficiency (EE) were calculated. The optimal formulations for each drug molecule were analysed using PCS, zeta potential measurement and TEM, as previously described. The formulations were freeze-dried and ATR-FTIR spectra obtained.
In vitro drug release from nano-aggregates
The formulation (2 mL) was pipetted inside dialysis tubing (MW cut off = 12-14 kDa) and dialysed against PBS under 'sink conditions' (200 mL, 0.2 M) at 37 ºC with stirring. At various time points, 1 mL of the external PBS was extracted and replaced with 1 mL of fresh PBS. The drug concentration in PBS was determined using UVVis and fluorescent spectroscopy, as previously described.
Biological characterisation of nano-aggregates and formulations
BxPC-3 cells were maintained using RPMI media supplemented with 10% foetal bovine serum and 1% penicillin streptomycin. Cells were grown in an incubator at 37 °C and 5% CO 2 .
The Drug uptake studies were carried out after 4 h incubation of the novel formulations of 6-TG and BNIPDaoct.
Cells were seeded in a 6-well plate (50,000 cells/well) and incubated with 50 µgmL -1 drug concentration (in formulation compared with free drug). Plates were incubated for 4 h at 37 °C, 5% CO 2 before the media was removed and the cells washed three times with phosphate buffered saline (PBS). The cells were trypsinised and resuspended in 1 mL media. Cells were counted on a Countess ® automated cell counter (Life Technologies, UK), 1 x10 6 cells transferred into an Eppendorf tube and centrifuged at 500 rpm for 5 min. The cell pellet was resuspended in deionised water (6-TG)/DMSO (BNIPDaoct) and vortexed for 30 seconds. The sample absorbance was recorded at 330 nm for the 6-TG and fluorescence at excitation 240 nm and emission 380 nm for the BNIPDaoct. Total drug concentration was calculated per cell in respect to calibration curves.
All statistical analysis was carried out using T-Test analysis within the Microsoft Excel ® software package.
Results
Synthesis and characterisation of PAA-Ox 5
PAA-Ox 5 polymers were fabricated via a simple substitution reaction between the primary amines in the parent PAA structure and the chloride functionality of the oxadiazole compound (Fig. 1) . 1 H NMR spectroscopy was used to identify whether polymer synthesis had been successful. The spectra ( Fig.2A) (Fig. 2B) . Here, characteristic peaks were observed at 3350 cm -1 and 2800 cm -1 which arise from the N-H stretching and C-H stretching in the PAA backbone, respectively. Additional peaks observed at 1900 cm -1 and 1600 cm -1 indicated that hydrophobic pendant group attachment had been successful due to these peaks being attributable to the bending and stretching vibrations of the aromatic ring C=C present in the oxadiazole structure. Elemental analysis was used to quantitatively determine the degree of molar substitution of oxadiazole onto the PAA backbone. The data suggested that 5.8% grafting had occurred; which was calculated from relative sulphur content (Table 1) .
Synthesis and characterisation of HNPs
Fe 3 O 4 magnetic nanoparticles were successfully synthesised using a common precipitation protocol [28, 47] . The polymers were subsequently electrostatically coated with PEI before gold coating. Each stage of the reaction was closely monitored using UV-Vis-NIR spectroscopy (Supplementary Data, Figure 1 ), photon correlation spectroscopy and zeta potential measurement ( Figure 2 ) and the particle diameter was determined to be 50 nm. Magnetic measurements were carried out using SQUID measurement. Here, the magnetization vs. applied field hysteresis loop was determined at 250K (Fig. 3A1) . The magnetic coercivity and saturation magnetization data obtained indicate that highly crystalline Fe 3 O 4 cores are present in the HNP structure which shows a high degree of order at room temperature. The zero field cooled/field cooled curve (Fig. 3A2 ) data shows the typical trend for ferromagnetic nanoparticles. The absence of a maximum in this data shows that the ordering temperature is above room temperature (25 o C).
Characterisation of PAA-Ox 5 and PAA-Ox 5 -HNP nano-aggregates
Nano-aggregates were formed upon probe sonication of the PAA amphiphiles in deionised water. The amphiphiles were characterised using TEM, PCS and zeta potential measurement. The TEM image (Fig. 1B1) of the PAA-Ox 5 aggregates shows micellar-like structures of approximately 47 nm in diameter which is smaller than the diameter gained through PCS measurement (72 nm), however; this is due to different sample preparation and measurement techniques. The TEM measures dried samples whereas, the PCS measures the hydrodynamic radius of the aggregates suspended in water, hence obtaining a larger value. The polydispersity index (PDI) of the PAA-Ox 5 was 0.330 indicating that the nano-aggregates were not totally monodisperse. A highly positive zeta potential measurement was obtained for this amphiphile (+41.9 mV) which is unsurprising due to the amine functionality within the parent PAA backbone.
HNP conjugation was achieved through dative covalent linkage between the colloidal gold surface of the HNP and the thiol functionality in the oxadiazole pendant group of the PAA-Ox 5 . It is believed that only one -SH group will be attached to one HNP due to the effects of steric hindrance coupled with the low concentration of HNPs added in the reaction. The TEM image (Fig. 1B2) indicates that attachment was successful. Here, nanoaggregate clusters are observed with small dense regions within the nano-aggregate core due to HNP attachment onto the randomly grafted oxadiazole pendants forming PAA-Ox 5 -HNP. After conjugation a sharp decrease in surface charge was observed, with the zeta potential decreasing to +19.1 mV. This decrease is possibly due to the incorporation of the HNPs which may still become visible to the instrument when the aggregates are forming and disrupting under dynamic equilibrium. An increase in hydrodynamic radius (235 nm) and TEM particle diameter (175 nm) was observed which indicates that after HNP incorporation, the aggregates are no longer capable of forming compact aggregates, possibly due to steric hindrance within the hydrophobic core. completely dried. This is to be expected with any magnetic nano-material being prepared and imaged in this manner. SQUID analysis showed that the polymer construct possessed magnetic properties which further confirmed the HNP conjugation was successful (Fig. 3B) . The signals obtained for M vs. T of the PAA-Ox 5 -HNP (Fig. 3B2) were understandably much smaller than for the HNPs alone ( Fig. 3A2 ) (10 -12 compared with 10 -10 ); this was due to only 5% of the total mass of the amphiphile being composed of HNPs.
The CAC was determined for both amphiphiles using a hydrophobic methyl orange UV probe (Fig. 4) . Here, a hypsochromic shift was observed in the λ max values for absorbance in the UV spectra. The inflection point at the beginning of the curve of λ max vs. polymer concentration is indicative of the CAC value [10] . The PAA-Ox 5 exhibited a CAC value at 0.093 mgmL -1 which decreased to 0.049 mgmL -1 after HNP attachment (PAA-Ox 5 -HNP). This decrease in CAC value suggests that HNP addition changes the degree of hydrophobic interaction between the oxadiazole pendant groups and, hence, reduced concentrations are required for aggregate formation.
Drug loading and in vitro drug release from nano-aggregates
The model hydrophobic drugs propofol and griseofulvin were incorporated into the nano-aggregate structure via hydrophobic-hydrophobic interactions (Fig. 5) . Polymer concentration and initial drug:polymer feed ratio were varied in order to determine the optimal drug loading parameters. Optimal drug loading for both propofol and griseofulvin was achieved at the 6 mgmL -1 polymer concentration and 10:1 initial drug:polymer feed ratio (Supplementary data, Fig. 3 ). Both PAA-Ox 5 and PAA-Ox 5 -HNP amphiphiles showed a polymer concentration and initial drug-feed dependant trend on drug solubilisation. Interestingly, the PAA-Ox 5 -HNP nanoparticles were consistently capable of higher drug encapsulation within their hydrophobic core; this could be due to the less compact nature of the aggregates accommodating a larger quantity of drug molecules ( nm, between unloaded and drug loaded aggregates, respectively (Fig. 1B and Fig. 6A1andA2) . A similar trend was observed in the hydrodynamic diameter measurements resulting from photon correlation spectroscopy (Table 1 ). The FTIR spectra of the freeze dried formulation (Supplementary data, Fig. 4A) showed the presence of an additional O-H peak at 3600 cm -1 compared with the unloaded polymers (Fig. 2B) , and the orthosubstituted benzene ring peaks at 748 cm -1 were due to the substitution pattern of the functional groups present on the propofol moiety; this indicated that propofol had been successfully encapsulated in the formulation. The griseofulvin solubility studies showed that PAA-Ox 5 and PAA-Ox 5 -HNP amphiphiles increased drug solubility by 53-fold and 56-fold, respectively, when compared with the intrinsic drug solubility. This resulted in 1.59 mgmL -1 and 1.68 mgmL -1 total drug solubilisation (Table 2) . Here, the encapsulation efficiency was reduced when compared with the propofol study. However, griseofulvin is a relatively much larger molecule (molecular weight = 353 gmol -1 ) compared to propofol (molecular weight = 178 gmol -1 ). Similar to the propofol study, nano-aggregate core expansion was observed upon drug loading when visualised using TEM (Fig. 6A2andB2) .
The FTIR spectra of the griseofulvin formulations showed extra peaks at 3359 cm -1 (O-H), 1650 cm -1 (C=O), 800 cm -1 (substituted benzene) and a weak peak at 550 cm -1 (Supplementary data, Fig. 4B ). These peaks correlate well with the functional groups present on the griseofulvin moiety.
The novel anticancer agent BNIPDaoct was loaded into the PAA-Ox 5 and PAA-Ox 5 -HNP aggregates using the optimal parameters identified from the propofol and griseofulvin studies (Polymer concentration 6 mgmL -1 , drug: polymer feed 10:1). BNIPDaoct (molecular weight = 781 gmol -1 ) is from a family of bisnaphthalimide compounds which have shown potential in cancer therapy. However, this specific analogue is hindered by its extremely hydrophobic nature, so much so in fact, that no measurable intrinsic aqueous solubility could be measured using the HPLC (coupled to a fluorescent detector) used in this study. Therefore, any increase in drug solubility is desirable. Once loaded into the respective PAA amphiphiles (PAA-Ox 5 and PAA-Ox 5 -HNP), 0.84 mgmL -1 and 0.92 mgmL -1 drug solubilisation was achieved. These values are somewhat lower than those achieved with propofol and griseofulvin. However, worthy of note, is that BNIPDaoct is a more sterically demanding molecule and therefore less drug may be capable of being physically accommodated within the nano-aggregate core. Interestingly, the TEM images in Fig. 6A3andB3 show spherical and uniform nanoaggregates compared with the other two formulations where irregular shaped aggregates were observed. A final study was also carried out using the hydrophilic anticancer agent 6-TG. Here, the rationale was to permanently conjugate the drug molecule to the HNP incorporated into the structure of the PAA-Ox 5 -HNP. Due to the hydrophilic nature of 6-TG, the mode of drug incorporation had to be achieved via a different mechanism to the previous studies, since no hydrophobic-hydrophobic interactions would occur (Fig. 5B) . A study was carried out using the PAA-Ox 5 merely as a control. As expected, the data obtained showed an increased drug concentration present within the PAA-Ox 5 -HNP core (2.8 mgmL -1 ) when compared with 0.5 mgmL -1 in the PAA-Ox 5 (Table   2) ; this was a 5-fold increase. The drug concentration encapsulated inside the PAA-Ox 5 is probably due to the drug molecules being dissolved in the surrounding aqueous media and not due to physical entrapment within the hydrophobic core. The TEM images show that core expansion upon drug loading only occurred in the PAAOx 5 -HNP and not the PAA-Ox 5 non-metallic amphiphile) (Fig. 6A4andB4) .
In vitro drug release studies were carried out under 'sink conditions' for all of the optimal formulations (Fig. 7) .
The studies were carried out over a period of 72 hrs. All of the hydrophobic drug formulations showed an initial 'burst' release over the first 4 hr period. Propofol was released consistently throughout the study period until 100% had been released at 72 hrs. Interestingly, the PAA amphiphiles containing the HNPs demonstrated slower drug release profiles compared with the PAA-Ox 5 . Griseofulvin and BNIPDaoct release followed similar trends whereby, after the initial burst phase, a plateau was observed. Across all drugs, the PAA-Ox 5 and PAAOx 5 -HNP formulations released 100% and 74% of drug over the 72 h study period, respectively. The
BNIPDaoct-loaded aggregates however, only released 25% (PAA-Ox 5 ) and 18% (PAA-Ox 5 -HNP) of total drug payload over the time tested, respectively. This was not a surprise, given the extremely hydrophobic nature of the drug molecule which leads to it being energetically more favourable for the drug to reside within the hydrophobic core compared to release into the aqueous phase. Interestingly, a diametric drug release profile was observed for 6-TG between the two amphiphile derivatives. That is, the PAA-Ox 5 formulation showed a 100% total drug release after 5 min. This confirms that the reported drug concentration was not, in fact, due to physical entrapment, but was due to the water-soluble drug being freely dissolved in the aqueous media. Thus, in just 5 min, drug diffusion from the formulation (in dialysis tubing) into the surrounding PBS had occurred. In contrast to this result, only 2% of 6-TG content was released from the PAA-Ox 5 -HNP formulation. Since the drug incorporation was not due to hydrophobic-hydrophobic interactions but was, rather, due to permanent covalent attachment, it may appear odd that any drug was released at all. However, taking into account the small amount of 6-TG freely dissolved in the aqueous media of the formulation (and not physically attached), this result seems reasonable.
Biological characterisation of nano-aggregates and novel formulations
The cytotoxicity of the novel PAA amphiphiles on human pancreatic adenocarcinoma (BxPC-3) cells was determined using an MTT assay. The unloaded nano-aggregates were incubated with the cells for 24 hr and the total cell viability estimated compared to control wells. Upon incubation, the data showed that 50% of the total cell number was viable (IC 50 8A ). This data therefore indicates that the incorporation of BNIPDaoct into PAA nano-aggregates can enhance its therapeutic effect. Drug loading studies were carried out and the total drug content quantified per cell (Fig. 8B ). Here, the results showed that after only 4 hr, 83-fold more drug had entered the cells in the PAA-Ox 5 compared with the free drug. Additionally, 104-fold more drug was present inside the BxPC-3 cells when incubated with the PAA-Ox 5 -HNP formulation. This significant increase in cellular internalisation is probably the major contributing factor to the large decrease in cell viability and IC 50 value after 24 hr (p<0.001).
Interestingly, a similar trend was observed in the PAA-Ox 5 -HNP formulation containing 6-TG. Here, a significant (p<0.001) 455-fold increase in drug uptake was observed after the 4h incubation period and a 21-fold decrease in IC 50 was recorded. The PAA-Ox 5 formulation resulted in a 4-fold increase in cellular drug uptake and 1-fold decrease in IC 50 , neither of which were statistically significant (p>0.001).
Discussion
Nanoparticulate drug delivery systems have been widely studied over the past decade. With ever-increasing knowledge and understanding, more sophisticated platforms are continually emerging -as this study demonstrates. Incorporation of HNPs into the amphiphilic polymer architecture results in bi-functional aggregates capable of simultaneous imaging and drug delivery. This study investigated the potential for incorporation of metallic HNPs into an amphiphilic graft polymer structure and the resultant physicochemical and biological effects this functionalization had. Previous work investigating HNPs as drug carriers has mainly focussed on surface conjugation of the drug to the particles [29, 48] . In this study, we successfully synthesised both PAA-Ox 5 amphiphile derivatives which were characterised by elemental analysis, 1 H NMR and FTIR (Fig.   2 ). Iron oxide nanoparticles were synthesised via wet chemical precipitation and coated with gold using an organic intermediate (PEI). These nanoparticles were successfully incorporated into the polymer structure via dative covalent bonding between the gold surface and thiol functionality of the oxadiazole pendant group. TEM, zeta potential measurement and SQUID analysis confirmed the presence of the HNPs on the polymer backbone (Fig. 1B, Table 1, Fig. 3B ). Nano-aggregates formed spontaneously in the aqueous environment and were characterised by PCS and TEM and their CAC determined using a hydrophobic methyl orange probe (Fig. 4) . which were dependant on the polymer architecture [6] . In a similar study, PAA conjugated with the hydrophobic pendant groups 9-Fluorenylmethoxy carbonyl (Fmoc), Dansyl and naphtholyl (Naphth) in 5% and 10% mole grafting ratios achieved CAC values of between 0.125 -0.5 mgmL -1 [11] . Our cytotoxicity studies of the PAA derivatives indicated IC 50 values of 60 µgmL -1 and 55 µgmL -1 for PAA-Ox 5 and PAA-Ox 5 -HNP, respectively (Fig. 8A) . Here, the IC 50 values for both amphiphiles are not significantly different (p>0.001). This work follows the extensive investigations into the stability and toxicity of HNPs in BxPC-3 cells that have been reported recently [29] . This study showed that over a 2 week period the HNPs appeared to be chemically stabile in physiological media (pH 4.6 and 7.2). No significant cell viability reduction was observed in the BxPC-3 cells after 1 week incubation up to 100 µgmL -1 . In addition, negligible cell membrane damage or free radical production was detected after 72 h incubations up to 25 µgmL -1 [29] .
Drug incorporation into the nano-aggregates was achieved by two mechanisms. Firstly, hydrophobic drug molecules are encapsulated within the hydrophobic core of the aggregates due to the preferential reduction in Gibbs' free energy (Fig. 5A) . Here, two model hydrophobic drugs, propofol and griseofulvin were used in order to investigate the optimal parameters, which included the polymer concentration and initial drug: polymer mass feed ratio for drug encapsulation to occur. Using the optimal formulation conditions identified in these studies (6 mgmL -1 polymer concentration and 10:1 initial drug:polymer feed ratio), an additional hydrophobic drug (BNIPDaoct) was investigated and incorporated into the core of the PAA amphiphiles in a similar manner (Supplementary data, Figure 3 ). Our drug solubilisation results were in agreement with previous studies on the drug loading of PAA amphiphiles [13] . Further, the PAA derivatives tested proved to be universal drug solubilizers for a range of hydrophobic drugs. The maximum solubilisation concentrations were recorded as 25.79 mgmL -1 , 1.68 mgmL -1 and 0.92 mgmL -1 for propofol, griseofulvin and BNIPDaoct, respectively (Table   2 ). Interestingly, these loading maxima were all achieved with the PAA-Ox 5 -HNP amphiphile. Perhaps, the less compacted core resulted in greater core expansion and thus drug accommodation resulting in greater drug loading and encapsulation efficiencies ( propofol and griseofulvin, respectively [13] . Here, the propofol results are comparable to ours at lower molar pendant grafting levels (5%) with the oxadiazole group, however, our griseofulvin solubilisation results are notably lower. The reason for this is not clear, although it could be due to the increased core expansion upon drug loading resulting in larger aggregates which were then removed during the filtering process. Other studies reported cholesterol modified PAA (Ch5) for BNIPDaoct solubilisation achieved 0.3 mgmL -1 drug encapsulation with 1 mgmL -1 polymer concentration, 5% mole cholesterol grafting and a 1:1 initial drug:polymer mass feed ratio [49] . Here, the PAA-Ox5-HNP formulation achieved a greater drug loading (0.9 mgmL -1 ) but with a lower % loading capacity (15% compared to the 30%) to the Ch5-BNIPDaoct formulation.
The second mechanism of drug incorporation concerned the conjugation of the model hydrophilic drug 6-TG onto PAA-Ox 5 -HNP amphiphile (via the HNP) (Fig. 5B ). This was achieved through dative covalent linkage between the colloidal gold surface and the thiol moiety in the 6-TG structure. 6-TG is a freely water-soluble drug and therefore encapsulation via hydrophobic-hydrophobic interaction should not occur; hence, PAA-Ox 5 was used as a control vehicle. The conjugation of 6-TG onto the PAA-Ox 5 -HNP structure could possibly protect the drug on its journey to target site and reduce undesirable side effects. Here, the data showed an exciting solubility increase to 2.8 mgmL -1 with PAA-Ox 5 -HNP compared with 0.5 mgmL -1 with PAA-Ox 5 . This indicates that the drug had successfully incorporated into the HNP-amphiphile structure which was also confirmed with an increase in nano-aggregate diameter using TEM (Fig. 6B4 ).
Biological investigations into the BNIPDaoct and 6-TG formulations showed consistently that greater cell uptake occurred after 4 h incubation with BxPC-3 cells compared with free drug. This exciting finding is in agreement with other studies which have shown that drugs either encapsulated or physically conjugated onto nanoparticulates experience enhanced cellular uptake [50] . Other work in BxPC-3 cells investigated the cellular response to 6-TG after its conjugation to the HNPs onto HNP surface showed enhanced cellular uptake of the conjugated 6-TG when compared with free drug with a resulting 10-fold decrease in IC 50 [29] . At these drug concentrations the polymer level is below its CAC. However, the added hydrophobicity of the drug molecule into the intrinsic structure of the nano-aggregate may be enough to stabilize the system. Little is known in this area as previous studies have observed that even at polymer concentrations below IC 50 in vivo enhancement in drug efficacy occurs [49] . 50 between free drug and formulation (p<0.001). ** denotes level of significance increase in drug uptake between free drug and formulation (p<0.001). 
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